204 related articles for article (PubMed ID: 18460027)
1. Abnormal AP-1 protein expression in primary cutaneous B-cell lymphomas.
Mao X; Orchard G
Br J Dermatol; 2008 Jul; 159(1):145-51. PubMed ID: 18460027
[TBL] [Abstract][Full Text] [Related]
2. Abnormal activator protein 1 transcription factor expression in CD30-positive cutaneous large-cell lymphomas.
Mao X; Orchard G; Russell-Jones R; Whittaker S
Br J Dermatol; 2007 Nov; 157(5):914-21. PubMed ID: 17725669
[TBL] [Abstract][Full Text] [Related]
3. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
[TBL] [Abstract][Full Text] [Related]
4. IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma.
Koens L; Vermeer MH; Willemze R; Jansen PM
Am J Surg Pathol; 2010 Jul; 34(7):1043-8. PubMed ID: 20551823
[TBL] [Abstract][Full Text] [Related]
5. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomas.
Kaune KM; Neumann C; Hallermann C; Haller F; Schön MP; Middel P
Exp Dermatol; 2011 Apr; 20(4):331-5. PubMed ID: 21410763
[TBL] [Abstract][Full Text] [Related]
7. Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cells.
Felcht M; Heck M; Weiss C; Becker JC; Dippel E; Müller CS; Nashan D; Sachse MM; Nicolay JP; Booken N; Goerdt S; Klemke CD
Br J Dermatol; 2012 Aug; 167(2):348-58. PubMed ID: 22512270
[TBL] [Abstract][Full Text] [Related]
8. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group.
Senff NJ; Willemze R
Br J Dermatol; 2007 Dec; 157(6):1205-11. PubMed ID: 17941944
[TBL] [Abstract][Full Text] [Related]
9. The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinical findings, histology, and immunohistochemistry.
Felcht M; Booken N; Stroebel P; Goerdt S; Klemke CD
J Am Acad Dermatol; 2011 Jan; 64(1):135-43, 143.e1-4. PubMed ID: 21167409
[TBL] [Abstract][Full Text] [Related]
10. Comparative genomic hybridization analysis of cutaneous large B-cell lymphomas.
Giménez S; Costa C; Espinet B; Solé F; Pujol RM; Puigdecanet E; García-Moreno P; Sánchez J; Gallardo F; Estrach T; García-Muret P; Romagosa V; Serrano S; Servitje O
Exp Dermatol; 2005 Dec; 14(12):883-90. PubMed ID: 16274455
[TBL] [Abstract][Full Text] [Related]
11. Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma.
Trøen G; Nygaard V; Jenssen TK; Ikonomou IM; Tierens A; Matutes E; Gruszka-Westwood A; Catovsky D; Myklebost O; Lauritzsen G; Hovig E; Delabie J
J Mol Diagn; 2004 Nov; 6(4):297-307. PubMed ID: 15507668
[TBL] [Abstract][Full Text] [Related]
12. Expression of TCL1 and CD27 in primary cutaneous B-cell lymphomas.
Pescarmona E; Remotti D; Perez M; Monaco S; Pacchiarotti A; Faraggiana T; Russo G; Baroni CD
Histopathology; 2006 Oct; 49(4):343-8. PubMed ID: 16978196
[TBL] [Abstract][Full Text] [Related]
13. Profiling of apoptosis genes identifies distinct types of primary cutaneous large B cell lymphoma.
van Galen JC; Hoefnagel JJ; Vermeer MH; Willemze R; Dijkman R; Tensen CP; de Boer WP; Meijer CJ; Oudejans JJ
J Pathol; 2008 Jul; 215(3):340-6. PubMed ID: 18498125
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous B-cell lymphoma: important diagnostic tools.
Ferenczi K
G Ital Dermatol Venereol; 2010 Jun; 145(3):361-73. PubMed ID: 20461044
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of p16INK4a/CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomas.
Belaud-Rotureau MA; Marietta V; Vergier B; Mainhaguiet G; Turmo M; Idrissi Y; Ferrer J; Beylot-Barry M; Dubus P; Merlio JP
Virchows Arch; 2008 Jun; 452(6):607-20. PubMed ID: 18311490
[TBL] [Abstract][Full Text] [Related]
16. Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification.
Senff NJ; Hoefnagel JJ; Neelis KJ; Vermeer MH; Noordijk EM; Willemze R;
Arch Dermatol; 2007 Dec; 143(12):1520-6. PubMed ID: 18087001
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment.
Paulli M; Lucioni M; Maffi A; Croci GA; Nicola M; Berti E
G Ital Dermatol Venereol; 2012 Dec; 147(6):589-602. PubMed ID: 23149705
[TBL] [Abstract][Full Text] [Related]
18. Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma.
Dijkman R; Tensen CP; Jordanova ES; Knijnenburg J; Hoefnagel JJ; Mulder AA; Rosenberg C; Raap AK; Willemze R; Szuhai K; Vermeer MH
J Clin Oncol; 2006 Jan; 24(2):296-305. PubMed ID: 16330669
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea.
Kim MJ; Hong ME; Maeng CH; Jung HA; Hong JY; Choi MK; Kim SJ; Ko YH; Kim WS
Int J Hematol; 2015 Mar; 101(3):273-8. PubMed ID: 25552248
[TBL] [Abstract][Full Text] [Related]
20. Expression of programmed death-1 (CD279) in primary cutaneous B-cell lymphomas with correlation to lymphoma entities and biological behaviour.
Mitteldorf C; Bieri M; Wey N; Kerl K; Kamarachev J; Pfaltz M; Kutzner H; Roncador G; Tomasini D; Kempf W
Br J Dermatol; 2013 Dec; 169(6):1212-8. PubMed ID: 23937075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
